Journal profile · Biochemistry & Molecular Biology
Current Medicinal Chemistry
ISSN 0929-8673 · eISSN 1875-533X · Bentham Science Publishers B.V. · NETHERLANDS · Semimonthly · Founded 1994
Current Medicinal Chemistry: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 3.08; hybrid open access; median 103 days to acceptance (57 articles, last 24 months); community-reported acceptance: about 20%; 359 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Current Medicinal Chemistry is published by Bentham Science Publishers B.V. and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Computational Drug Discovery Methods, Synthesis and biological activity and Cancer Mechanisms and Therapy, together about 23.3% of its articles. Its main subfields are Molecular Biology. (generated from OpenAlex topic counts and CAS ranking data)
Aims & Scope Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews and guest edited thematic issues written by leaders in the field covering a range of the current topics in medicinal chemistry. The journal also publishes reviews on recent patents. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.
Source: LetPub
Research area (LetPub): Biochemistry & Molecular Biology
Main research topics OpenAlex counts of recent articles; shares are approximate
- Computational Drug Discovery MethodsComputer Science10.3%
- Synthesis and biological activityChemistry7%
- Cancer Mechanisms and TherapyMedicine6.1%
- 14-3-3 protein interactionsBiochemistry, Genetics and Molecular Biology5.4%
- Diverse Scientific and Economic StudiesEconomics, Econometrics and Finance5.2%
- Chemical Synthesis and AnalysisBiochemistry, Genetics and Molecular Biology5.2%
- Click Chemistry and ApplicationsChemistry4.9%
- Nanoparticle-Based Drug DeliveryMaterials Science4.4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Biochemistry & Molecular Biology | Zone 4 |
| Minor | Chemistry, Medicinal | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: yes
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Biochemistry & Molecular Biology | Zone 3 |
| Minor | Chemistry, Medicinal | Zone 3 |
| Minor | Pharmacology & Pharmacy | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Biochemistry & Molecular Biology | Zone 3 |
| Minor | Chemistry, Medicinal | Zone 3 |
| Minor | Pharmacology & Pharmacy | Zone 3 |
Top journal: noReview journal: yes
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 3.08LetPub ·
- CiteScore 2026-06
- 6.5LetPub ·
- SJR 2026-06
- 0.74LetPub ·
- SNIP 2026-06
- 0.74LetPub ·
- h-index
- 158LetPub ·
- h-index
- 231OpenAlex ·
- i10-index
- 5,913OpenAlex ·
- 2-year mean citedness
- 2.67OpenAlex ·
- Self-citation rate
- 3.1%LetPub ·
- Share of gold OA articles
- 7.03%LetPub ·
Volume
- Articles per year
- 370LetPub ·
Articles by year OpenAlex count · 9,304 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 409 | 17 | 72 |
| 2025 | 359 | 53 | 657 |
| 2024 | 472 | 55 | 2,577 |
| 2023 | 416 | 40 | 3,299 |
| 2022 | 398 | 31 | 4,324 |
| 2021 | 521 | 89 | 7,445 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
103 daysMedian, submission to acceptance · P25–P75 86 days – 143 days
- Acceptance to online
- median 157 days (57 articles)
- Submission to online
- median 293 days
- Sample
- 57 articles with submission and acceptance dates (1,282 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 3 monthsLetPub ·
- Average acceptance (community reports)
- 20%LetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
No source has fee information yet; check the journal's website.
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Bentham Science Publishers B.V.
- Country or region
- NETHERLANDS
- Language
- English
- Frequency
- Semimonthly
- Founded
- 1994
- ISSN
- 0929-8673
- Electronic ISSN
- 1875-533X
- Official links
- Journal homepage ↗LetPub
- Submission system ↗LetPub
FAQ
Frequently asked questions about Current Medicinal Chemistry
What CAS zone is Current Medicinal Chemistry in?
In the 2025 upgraded edition of the CAS Journal Ranking, Current Medicinal Chemistry is in Zone 4 of Medicine, and in Zone 4 of the minor category Biochemistry & Molecular Biology / Chemistry, Medicinal / Pharmacology & Pharmacy. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Current Medicinal Chemistry?
The latest impact factor listed by LetPub is 3.08; CiteScore 6.5, h-index 231.
How long does peer review take at Current Medicinal Chemistry?
Based on the dates recorded on 57 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 103 days (interquartile range 86–143 days); authors report an average review time of about 3 months; the community-reported acceptance is “about 20%”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Current Medicinal Chemistry?
According to LetPub and DOAJ records, Current Medicinal Chemistry is indexed in SCIE and Scopus.
Is Current Medicinal Chemistry open access, and what is the APC?
Current Medicinal Chemistry is a hybrid journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .